Three-Month Dual Antiplatelet Therapy After Implantation of Zotarolimus-Eluting Stents - The DATE (Duration of Dual Antiplatelet Therapy After Implantation of Endeavor Stent) Registry -
Joo‐Yong Hahn(Samsung Medical Center), The DATE Registry Investigators, Do‐Sun Lim(Korea University), Seung‐Ho Hur(Keimyung University Dongsan Medical Center), Young Bin Song(Samsung Medical Center), Sung Yun Lee(Inje University), Kyoo‐Rok Han(Hallym University Kangnam Sacred Heart Hospital), Byung Ryul Cho(Kangwon National University), Seung‐Woon Rha, Sahng Lee(Hanyang University Seoul Hospital), Hun Sik Park(Kyungpook National University Hospital), Sang Hoon Lee(Eulji University), Jongsun Park(Chungnam National University), Junghan Yoon(University of Ulsan), Hyeon‐Cheol Gwon(Samsung Medical Center), Jin‐Ho Choi(Ulsan College), Sung‐Hyuk Choi(Boston University)
Cited by 26
Related Papers
Randomized Trial of Stents versus Bypass Surgery for Left Main Coronary Artery Disease
|New England Journal of Medicine|2011|683
A New Strategy for Discontinuation of Dual Antiplatelet Therapy
|Journal of the American College of Cardiology|2012|643
Effect of Intravascular Ultrasound–Guided vs Angiography-Guided Everolimus-Eluting Stent Implantation
|JAMA|2015|603
Duration of Dual Antiplatelet Therapy after Implantation of Drug-Eluting Stents
|New England Journal of Medicine|2010|510
Trial of Everolimus-Eluting Stents or Bypass Surgery for Coronary Disease
|New England Journal of Medicine|2015|505